Benzinga's M&A Chatter for Thursday April 16, 2015

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday April 16, 2015: CollabRx, Medytox to Merge The Deal:
CollabRx, Inc. CLRX and Medytox Solutions MMMS announced Thursday, that they have entered into a definitive merger agreement. Under the agreement, CollabRx equityholders will own a 10% stake in the combined company and Medytox equityholders will own 90% of the combined company. CollabRx shares rose 9% Thursday, closing at $1.14. Macerich's Fourth Largest Shareholder Wants Plan to Produce as Much Value as Rejected Simon Bid The Shareholder Comments:
The Macerich Company MAC shareholder, Cohen & Steers Inc CNS asked Macerich to come up with a plan to deliver the same value as was offered by Simon Property Group Inc SPG, when they offered $95.50 per share. Cohen & Steers' Executive Chairman Martin Cohen told Reuters on Wednesday, that he favored Simon's offer, which was rejected by Macerich. A Macerich spokesman declined to comment on the Cohen comments. Macerich shareholders Land and Buildings and Orange Capital also expressed their dissatisfaction at the rejected Simon offer in a letter to Macerich Chairman and CEO Art Coppola. Macerich shares gained $0.69 Thursday, closing at $82.99. Report Says Intel May be Leaning Toward Xilinx The Rumor:
Shares of Xilinx Inc. XLNX rose Thursday, on a Deal Reporter story that Intel Corporation INTC might be leaning toward an acquisition of Xilinx, versus the previously rumored Altera Corp ALTR. The Wall Street Journal first reported on March 27, that Intel was in talks to acquire Altera. Those talks reportedly ended without an agreement, when Altera rejected a $54.00 per share offer, according to sources. Xilinx shares gained $0.43 Thursday, closing at $44.33. Alter shares lost $0.07, closing at $43.35.